Quince Therapeutics Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 33 institutions reported holding Quince Therapeutics Inc. in their 13F filings, down 10 from Q2 2024. 2 opened new positions and 12 sold out. The largest holders were Vanguard Group Inc. ($931K), EPIQ Capital Group, LLC ($641K) and Renaissance Technologies ($406K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Quince Therapeutics Inc.
- CUSIP
- 22053A107
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $431K |
| Exits | 12 | $1.3M |
All 13F filers, Q2 2024 → Q3 2024: 785,214 shares bought and 1,842,720 shares sold, net −1,057,506 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 33 holders
| Vanguard Group Inc. | 0.00% | Reduce -1.2% | 1,199,648 | $931K |
| EPIQ Capital Group, LLC | 0.18% | Reduce -3.1% | 825,942 | $641K |
| Renaissance Technologies | 0.00% | Add +8.0% | 522,576 | $406K |
| Almitas Capital LLC | 0.11% | New | 382,882 | $297K |
| BlackRock, Inc. | 0.00% | — | 358,358 | $278K |
| HighTower Advisors, LLC | 0.00% | No change | 341,570 | $273K |
| Geode Capital Management, LLC | 0.00% | Add +24.2% | 339,125 | $263K |
| Alphabet Inc. | 0.01% | No change | 189,122 | $148K |
| Shay Capital LLC | 0.04% | New | 172,183 | $134K |
| Bank of America Corp. | 0.00% | Add +0.0% | 157,978 | $123K |
| ADAR1 Capital Management, LLC | 0.02% | Add +53.8% | 142,958 | $111K |
| Mariner, LLC | 0.00% | Add +65.3% | 122,461 | $95K |
| Citadel Advisors | 0.00% | Add +7.2% | 107,007 | $83K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -36.1% | 88,495 | $69K |
| State Street Corp. | 0.00% | No change | 56,611 | $44K |
| Intellectus Partners, LLC | 0.01% | Add +0.4% | 53,527 | $42K |
| Northern Trust Corp. | 0.00% | No change | 34,023 | $26K |
| Susquehanna International Group, LLP | 0.00% | Reduce -67.0% | 32,553 | $25K |
| XTX Topco Ltd | 0.00% | Add +53.2% | 21,570 | $17K |
| Citigroup Inc. | 0.00% | Add +231.6% | 17,127 | $13K |
| Nixon Peabody Trust Co. | 0.00% | No change | 11,126 | $9K |
| Morgan Stanley | 0.00% | No change | 8,522 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -42.3% | 5,549 | $4K |
| JPMorgan Chase & Co. | 0.00% | Add +16.8% | 548 | $425 |
| UBS Group AG | 0.00% | No change | 480 | $373 |
| CoreCap Advisors, LLC | 0.00% | No change | 431 | $335 |
| JDM Financial Group LLC | 0.00% | No change | 340 | $264 |
| Financial Perspectives, Inc | 0.00% | No change | 310 | $241 |
| Parallel Advisors, LLC | 0.00% | No change | 295 | $229 |
| Osaic Holdings, Inc. | 0.00% | No change | 277 | $216 |
| Barclays PLC | 0.00% | No change | 100 | $78 |
| Financial Avengers, Inc. | 0.00% | No change | 100 | $78 |
| Westside Investment Management, Inc. | 0.00% | No change | 75 | $58 |
"% of holder's portfolio" is QUINCE THERAPEUTICS INC's weight in each manager's 13F, not the share of Quince Therapeutics Inc. the manager owns.